Contrary to many cancer cell models, siRNA-based FAK inhibition is probably not a useful strategy to prevent epithelial overgrowth and the dysbalanced expression of GKs differentiation markers, as can be concluded from our data. This evidence concerns the gene PTK2 and cancer.